Validations: Ongoing Review & Risk Scoring
Exit Readiness: Offboarding Without Quality Debt Exit Readiness: Offboarding Without Quality Debt In the highly regulated pharmaceutical industry, the concept of offboarding vendors, including Contract Manufacturing Organizations (CMOs), Contract Development and Manufacturing Organizations (CDMOs), and tech providers, is critical. The challenges associated with this offboarding process can vary, but they all hinge on maintaining quality standards. This guide will navigate…
Exit Readiness: Offboarding Without Quality Debt Exit Readiness: Offboarding Without Quality Debt In the pharmaceutical industry, effective vendor management is crucial to ensure compliance with regulatory standards and to maintain quality throughout the supply chain. As companies navigate supplier qualification, quality agreements, and ongoing risk assessments, it becomes imperative to develop a structured exit readiness strategy when dealing with suppliers,…
Top Ongoing Review Gaps—and Fixes The pharmaceutical industry is governed by stringent regulations to ensure that products are safe and effective. As such, managing ongoing reviews of suppliers, Contractors Manufacturing Organizations (CMOs), and tech providers is pivotal for compliance and operational excellence. In this article, we will systematically explore the ongoing review gaps that practitioners encounter and provide actionable fixes….
Templates: Risk Scores, AVL, QBR Minutes Templates: Risk Scores, AVL, QBR Minutes In today’s pharmaceutical landscape, the continuous assessment and management of risk associated with suppliers and contract manufacturing organizations (CMOs) are paramount. This tutorial provides pharmaceutical professionals with a comprehensive guide on developing risk scores, utilizing Auditing Vendor Lists (AVL), and conducting Quarterly Business Reviews (QBR). Understanding these processes…
Peer Review Checklists for Ongoing Review Peer Review Checklists for Ongoing Review In the pharmaceutical industry, ensuring the integrity and quality of products is paramount. A structured and compliant approach to supplier qualification and oversight can significantly mitigate risks associated with outsourcing to Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). This tutorial provides a step-by-step guide…
Risk-Based Sampling at Incoming/Release: A Comprehensive Guide In the pharmaceutical industry, ensuring product quality is paramount across each stage of the supply chain. Risk-based sampling at the incoming and release stages can significantly enhance supplier qualification and oversight of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). This guide aims to provide a step-by-step approach to implementing…
Supplier KPIs in Management Review Supplier KPIs in Management Review Introduction to Supplier KPoys in Management Review In today’s highly regulated pharmaceutical environment, managing supplier quality is paramount. The risk associated with supplier relationships can significantly impact the success of pharmaceutical operations. This article serves as a comprehensive step-by-step guide to understanding the importance of Supplier Key Performance Indicators (KPIs)…
Storyboarding Ongoing Review for Inspections Storyboarding Ongoing Review for Inspections In the complex field of pharmaceutical operations, the ongoing review is an essential process that ensures compliance with regulatory expectations while maintaining the highest levels of quality. This tutorial guide serves as a comprehensive roadmap for pharmaceutical professionals engaged in supplier, CMO/CDMO oversight, and technology provider management. It outlines a…
Storyboarding Ongoing Review for Inspections Introduction to Ongoing Review and Inspections Pharmaceutical manufacturing is under constant scrutiny from regulatory bodies such as the FDA, EMA, MHRA, and PIC/S. Ongoing review for inspections serves as a proactive approach to ensure adherence to cGMP (current Good Manufacturing Practices) and regulatory requirements throughout the product lifecycle. This article explores how to effectively storyboard…
Data Integrity Signals in Ongoing Review In the pharmaceutical industry, ensuring compliance and quality standards across the supply chain is paramount. This requires not only a stringent supplier qualification process but also an effective ongoing review mechanism. This tutorial provides a comprehensive step-by-step guide for pharma professionals involved in ongoing reviews and risk assessments of suppliers, CMOs, and other partners….